Clinical Trial Update: A Study of LY3971297 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating LY3971297 in healthy participants is currently recruiting; the trial lists obesity and hypertension as conditions of interest.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• LY3971297

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Obesity | Phase 1 | Status: RECRUITING